PART I . Overview We are a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology that are intended to efficiently deliver improved cancer treatments. We have deep experience in chemistry, formulation, and drug delivery, as well as research, clinical, and commercial pharmaceutical development, resulting in successfully taking product candidates from the clinic to approval, launch, and commercialization. In December 2024, we entered into an intell...
Q2 FY2026 — expected 2026-08-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001193125-26-104158 | EDGAR | 110K words |
| 2025-03-28 | 2024-12-31 | 0001628280-25-015269 | EDGAR | — |
| 2024-03-13 | 2023-12-31 | 0001628280-24-010901 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0001628280-23-009583 | EDGAR | — |
| 2022-03-17 | 2021-12-31 | 0001564590-22-010721 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012252 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001564590-20-011174 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001564590-19-006602 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001564590-18-005868 | EDGAR | — |
| 2017-03-07 | 2016-12-31 | 0001213900-17-002066 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-337933 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001193125-25-268895 | EDGAR | 81K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-105081 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023932 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001628280-24-045698 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001628280-24-035636 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001628280-24-021657 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001628280-23-037905 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001628280-23-028562 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001628280-23-017234 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001628280-22-029228 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001628280-22-022208 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-337069 | EDGAR | — |
| 2026-03-12 | 0001193125-26-103117 | EDGAR | 2K words |
| 2025-11-06 | 0001193125-25-268134 | EDGAR | — |
| 2025-08-07 | 0000950170-25-104592 | EDGAR | — |
| 2025-06-13 | 0001193125-25-140810 | EDGAR | — |
| 2025-05-08 | 0001628280-25-023788 | EDGAR | — |
| 2025-03-26 | 0001193125-25-063253 | EDGAR | — |
| 2025-03-18 | 0001193125-25-056708 | EDGAR | — |
| 2025-03-04 | 0001193125-25-045605 | EDGAR | — |
| 2024-12-20 | 0001193125-24-282407 | EDGAR | — |
208 total filings indexed. 176 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001422142 |
| Ticker | WHWK |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.whitehawktx.com |
| Listed | 2021-08-27 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/WHWK (~200 tokens, structured JSON with cryptographic provenance)